- Practice Fusion sold for $100 million, after reports in 2016 said the company might go public at a $1.5 billion valuation.
- Documents show the company was looking for a buyer and that bids were a fraction of that price.
- Executives pulled in millions as part of a pre-arranged deal, while common shareholders were wiped out.
Karl-Josef Hildenbrand | AFP | Getty Images
When Practice Fusion, a medical records start-up, sold to AllScripts for $100 million this month, it was a massive disappointment for employees and investors. Only two years earlier, their stock in the company was reportedly worth 15 times the purchase price.
Start-ups crash and burn all the time. It's an inherent risk and one that's understood across Silicon Valley.
1
When someone talks down to you, use Dolly Parton's simple trick to 'maintain your dignity and disarm' them, says expert 2
Trump says U.S. is not forcing Iran to negotiate after fresh round of strikes 3
China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says 4
Canada's Carney slaps Trump admin for 'doing memes ... throwing shade' 5
Global bond yields soar to multi-decade highs as Middle East turmoil reignites inflation fears